DR. DANIEL J DILORENZO, MD, PHD
Medical Practice at 17 Ave, Seattle, WA
License number
Washington BP10026959
Category
Medical Practice
Type
Neurological Surgery
License number
Washington MD60464676
Category
Medical Practice
Type
Neurological Surgery
Address
Address
2
550 17Th Ave FL 5TH, Seattle, WA 98122
PO Box 25608, Salt Lake City, UT 84125
PO Box 25608, Salt Lake City, UT 84125
Phone
(206) 386-3880
(206) 386-3882 (Fax)
(206) 320-4476
(206) 568-7043 (Fax)
(206) 386-3882 (Fax)
(206) 320-4476
(206) 568-7043 (Fax)
Professional information
Systems And Methods For Characterizing A Patient's Propensity For A Neurological Event And For Communicating With A Pharmacological Agent Dispenser
US Patent:
2007014, Jun 28, 2007
Filed:
Dec 28, 2005
Appl. No.:
11/322150
Inventors:
Mike Bland - Seattle WA, US
Kent Leyde - Sammamish WA, US
David Snyder - Bainbridge Island WA, US
Daniel Dilorenzo - Seattle WA, US
Kent Leyde - Sammamish WA, US
David Snyder - Bainbridge Island WA, US
Daniel Dilorenzo - Seattle WA, US
International Classification:
A61K 9/22
US Classification:
604890100
Abstract:
The present invention provides systems and methods for managing intake of a pharmacological agent. In one method of the present invention, the systems and methods are for controlling intake of an anti-epileptic drug. In such embodiments, one or more signals from a patient are processed to predict an onset of a seizure. Upon the prediction of the seizure, the patient is allowed to access the pharmacological agent in a pharmacological agent dispenser.
Apparatus And Method For Closed-Loop Intracranical Stimulation For Optimal Control Of Neurological Disease
US Patent:
6366813, Apr 2, 2002
Filed:
Jun 25, 1999
Appl. No.:
09/340326
Inventors:
Daniel J. DiLorenzo - Salt Lake City UT 84103
International Classification:
A61N 100
US Classification:
607 45
Abstract:
A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a ânervous system component. â The neurological control system generates neural modulation signals delivered to a nervous system component through one or more intracranial (IC) stimulating electrodes in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition. Neural modulation signals include any control signal which enhances or inhibits cell activity. Significantly the neurological control system considers neural response, in the form of the sensory feedback, as an indication of neurological disease state and/or responsiveness to therapy, in the determination of treatment parameters.
Method, Apparatus, And Surgical Technique For Autonomic Neuromodulation For The Treatment Of Disease
US Patent:
2006016, Jul 27, 2006
Filed:
Jun 13, 2005
Appl. No.:
11/151816
Inventors:
Daniel DiLorenzo - Seattle WA, US
International Classification:
A61N 1/08, A61N 1/362, A61N 1/34, A61N 1/05
US Classification:
607002000, 607040000, 607044000, 607009000, 607045000, 607041000, 607058000, 607046000, 607117000, 607018000
Abstract:
The present invention teaches a method and apparatus for physiological modulation, including neural and gastrointestinal modulation, for the purposes of treating several disorders, including obesity, depression, epilepsy, and diabetes. This includes chronically implanted neural and neuromuscular modulators, used to modulate the afferent neurons of the sympathetic nervous system to induce satiety. Furthermore, this includes neuromuscular stimulation of the stomach to effect baseline and intermittent smooth muscle contraction to increase gastric intraluminal pressure, which induces satiety, and stimulate sympathetic afferent fibers, including those in the sympathetic trunk, splanchnic nerves, and greater curvature of the stomach, to augment the perception of satiety.
Methods And Systems For Determining Subject-Specific Parameters For A Neuromodulation Therapy
US Patent:
2007016, Jul 19, 2007
Filed:
Dec 29, 2006
Appl. No.:
11/647700
Inventors:
Daniel DiLorenzo - Seattle WA, US
Assignee:
BioNeuronics Corporation - Seattle WA
International Classification:
A61N 1/36
US Classification:
607045000
Abstract:
A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state and prevent neurological signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.
Method, Apparatus, And Surgical Technique For Autonomic Neuromodulation For The Treatment Of Obesity
US Patent:
2006011, Jun 1, 2006
Filed:
Dec 22, 2005
Appl. No.:
11/317099
Inventors:
Daniel DiLorenzo - Seattle WA, US
International Classification:
A61N 1/08
US Classification:
607040000
Abstract:
The present invention teaches a method and apparatus for physiological modulation, including neural and gastrointestinal modulation, for the purposes of treating several disorders, including obesity, depression, epilepsy, and diabetes. This includes chronically implanted neural and neuromuscular modulators, used to modulate the afferent neurons of the sympathetic nervous system to induce satiety. Furthermore, this includes neuromuscular stimulation of the stomach to effect baseline and intermittent smooth muscle contraction to increase gastric intraluminal pressure, which induces satiety, and stimulate sympathetic afferent fibers, including those in the sympathetic trunk, splanchnic nerves, and greater curvature of the stomach, to augment the perception of satiety.
Closed-Loop Autonomic Neuromodulation For Optimal Control Of Neurological And Metabolic Disease
US Patent:
7974696, Jul 5, 2011
Filed:
Jul 23, 2005
Appl. No.:
11/187315
Inventors:
Daniel John DiLorenzo - Seattle WA, US
Assignee:
DiLorenzo Biomedical, LLC - Galveston TX
International Classification:
A61N 1/00
US Classification:
607 45, 607 2, 607 62
Abstract:
A neurological control system for modulating activity of any component or structure of some or all of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component. ” This system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state or autonomic state and prevent neurological or metabolic signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals, with sensors configured to sense a particular characteristic indicative of a neurological, psychiatric, or metabolic condition.
Methods And Systems For Recommending An Appropriate Action To A Patient For Managing Epilepsy And Other Neurological Disorders
US Patent:
2007015, Jun 28, 2007
Filed:
Dec 28, 2005
Appl. No.:
11/321897
Inventors:
Kent Leyde - Sammamish WA, US
Daniel Dilorenzo - Seattle WA, US
Daniel Dilorenzo - Seattle WA, US
International Classification:
A61N 1/00
US Classification:
607045000
Abstract:
The present invention provides methods and system for managing neurological disorders such as epilepsy. In one embodiment, the method comprises measuring one or more signals from a patient and processing the one or more signals to characterize a patient's propensity for a future seizure. The characterized propensity for the seizure is thereafter used to determine an appropriate action for managing or treating the predicted seizure; and a recommendation is communicated to the patient that is indicative of the appropriate action.
Systems For Monitoring A Patient's Neurological Disease State
US Patent:
2010021, Aug 26, 2010
Filed:
May 5, 2010
Appl. No.:
12/774550
Inventors:
Daniel John DiLorenzo - Seattle WA, US
Assignee:
NeuroVista Corporation - Seattle WA
International Classification:
A61N 1/05
US Classification:
607 45
Abstract:
The present invention provides methods and systems for modulating a patient's neurological disease state. In one embodiment, the system comprises one or more sensors that sense at least one signal that comprise a characteristic that is indicative of a neurological disease state. A signal processing assembly is in communication with the one or more sensors and processes the at least one signal to estimate the neurological disease state and to generate a therapy to the patient that is based at least in part on the estimated neurological disease state. A treatment assembly is in communication with the signal processing assembly and delivers the therapy to a nervous system component of the patient.
Methods And Systems For Continuous Eeg Monitoring
US Patent:
2007016, Jul 12, 2007
Filed:
Dec 29, 2006
Appl. No.:
11/647785
Inventors:
Daniel DiLorenzo - Seattle WA, US
Assignee:
BioNeuronics Corporation - Seattle WA
International Classification:
A61B 5/04
US Classification:
600544000
Abstract:
A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state and prevent neurological signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.
Methods And Systems For Recommending An Appropriate Pharmacological Treatment To A Patient For Managing Epilepsy And Other Neurological Disorders
US Patent:
2007015, Jun 28, 2007
Filed:
Dec 28, 2005
Appl. No.:
11/321898
Inventors:
Daniel Dilorenzo - Seattle WA, US
Kent Leyde - Sammamish WA, US
Kent Leyde - Sammamish WA, US
International Classification:
A61N 1/00
US Classification:
607045000
Abstract:
The present invention provides systems and methods for managing epilepsy. In one embodiment, a method of the present invention characterize a patient's propensity for a future epileptic seizure and communicates to the patient and/or a health care provider a therapy recommendation. The therapy recommendation is typically a function of the patient's propensity for the future epileptic seizure.